Assignee
SERENITY PHARMACEUTICALS LLC
US5 patents
Top patents by PatentIndex Score
US11419914B2Aug 23, 2022
Safe desmopressin administration
SERENITY PHARMACEUTICALS LLC3 citations70
US9814753B2Nov 14, 2017
Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
SERENITY PHARMACEUTICALS LLC3 citations69
US9925232B2Mar 27, 2018
Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
SERENITY PHARMACEUTICALS LLC2 citations66
US10568927B2Feb 25, 2020
Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
SERENITY PHARMACEUTICALS LLC0 citations48
US10286033B2May 14, 2019
Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
SERENITY PHARMACEUTICALS LLC0 citations45